The mechanism of immune insufficiency against retroviral tumors and its restoration
The mechanism of immune insufficiency against retroviral tumors and its restoration
批准号:
15023217
负责人:
KANNAGI Mari
金额:
$10.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
人们注意到,成人T细胞白血病(ATL)与母婴感染有关,主要是通过母乳感染。在我们的大鼠系统中,口服感染的大鼠的持续人类T细胞白血病病毒I型(HTLV-I)载量显著高于腹腔感染的大鼠,而对HTLV-I的免疫反应明显弱于腹腔感染的大鼠。结果,持续病毒载量与病毒特异性T细胞反应水平呈负相关。然而,口服感染的大鼠的免疫反应不足可以通过皮下注射适当的抗原来恢复。我们还研究了非清髓性异基因外周血造血干细胞移植(HSCT)后获得完全缓解的ATL患者的细胞免疫反应,发现其中一些患者在HSCT后但在HSCT前没有强烈激活HTLV-I抗原特异性CTL反应。这些发现表明,在初次HTLV-I感染时建立的HTLV-I特异性免疫不足可能是ATL发生的潜在危险因素,但可以通过免疫学策略来克服。
英文摘要
It has been noted that adult T-cell leukemia (ATL) is incidentally associated with mother-to-child infection, mostly established via mother milk. In our rat system, orally infected rats exhibited significantly higher levels of persistent human T-cell leukemia virus type I (HTLV-I) load and much weaker immune response to HTLV-I than that in intraperitoneally infected rats. As a result, persistent viral load was inversely correlated with levels of virus-specific T-cell responses. The insufficient immune responses in orally infected rats could be, however, recovered by subcutaneous re-immunization with appropriate antigens. We also investigated cellular immune responses of ATL patients who obtained complete remission following non-myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling donors, and found that HTLV-I Tax-specific CTL response was strongly activated in some of these patients post-HSCT but not before HSCT. These findings suggest that HTLV-I-specific immune insufficiency established at primary HTLV-I infection may be an underlying risk factor for development of ATL, but could be overcome with immunological strategies.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Liu, T.Ohashi, T.Masuda.X.Zhou, M.Kubo, M.Kannagi: "Suppression of HIV-I replication by HIV-I-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-I-infected cells in vitro."Viral Immunology. 16. 381-393 (2003)
H.Liu、T.Ohashi、T.Masuda.X.Zhou、M.Kubo、M.Kannagi:“通过与 HIV-1 无关的 CD8 细胞毒性 T 淋巴细胞抑制 HIV-1 复制,导致持续保存 HIV-1-
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/ijc.20737
发表时间:
2005-03-20
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
[Kurihara, K, Harashima, N, Kannagi, M]
通讯作者:
Kannagi, M
Future prophylaxis and immunotherapy for adult T cell leukemia.
成人 T 细胞白血病的未来预防和免疫治疗。
DOI:
--
发表时间:
2004
期刊:
Expert Review of Anticancer Therapy 4
影响因子:
--
作者:
[M.Kannagi, et al.]
通讯作者:
et al.
Correlation of major hi stocompatibi1ity complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合体 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI:
--
发表时间:
2002
期刊:
J.Virol. 76
影响因子:
--
作者:
[T.Ohashi, S.Hanabuchi, R.Suzuki, H.Kato, H.Tateno, T.Masuda, M.Kannagi.]
通讯作者:
M.Kannagi.
Correlation of major histocompatibility complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合物 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI:
--
发表时间:
2002
期刊:
J.Virol. 76
影响因子:
--
作者:
[T.Ohashi, et al.]
通讯作者:
et al.
共 15 条
Host innate immune mechanisms separating inflammatory or lymphoproliferative diseases in HTLV-1 infection
-
批准号:20K07512
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:KANNAGI Mari
-
依托单位:
Anti-viral immuno therapeutic approaches for adult T-cell leukemia
-
批准号:17013028
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$31.04万
-
财政年份:2005
-
负责人:KANNAGI Mari
-
依托单位:
Role of vertical transmission of HTLV-I on the risk for T cell malignancy
-
批准号:12470052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:2000
-
负责人:KANNAGI Mari
-
依托单位:
Spontaneous inhibition of HTL V-I expression in the peripheral blood
-
批准号:06670333
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.58万
-
财政年份:1994
-
负责人:KANNAGI Mari
-
依托单位:
Characterization of the HTLV-I receptor
-
批准号:04670276
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.32万
-
财政年份:1992
-
负责人:KANNAGI Mari
-
依托单位:
海外基金